Shanghai Pharmaceuticals Holding Co., Ltd (SHA:601607)

China flag China · Delayed Price · Currency is CNY
17.25
+0.05 (0.29%)
Mar 2, 2026, 3:00 PM CST
-11.13%
Market Cap 57.44B
Revenue (ttm) 280.69B
Net Income (ttm) 5.65B
Shares Out 3.71B
EPS (ttm) 1.53
PE Ratio 11.28
Forward PE 21.63
Dividend 0.41 (2.38%)
Ex-Dividend Date Jan 5, 2026
Volume 13,332,686
Average Volume 12,074,019
Open 17.11
Previous Close 17.20
Day's Range 17.08 - 17.28
52-Week Range 17.07 - 19.68
Beta 0.35
RSI 40.69
Earnings Date Mar 31, 2026

About SHA:601607

Shanghai Pharmaceuticals Holding Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical and healthcare products in China and internationally. It operates through four segments: Production, Distribution, Retail, and Others. The company offers chemical and biological drugs, Chinese medicine, health care products, and medical devices to treat immunology, psychiatric and neurological, tumor, cardiovascular, digestive metabolism, psychoneurotic, neoplasm, respiratory system, and anti-infection diseases, as well as in... [Read more]

Sector Healthcare
Founded 1994
Employees 50,120
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 601607
Full Company Profile

Financial Performance

In 2024, SHA:601607's revenue was 275.25 billion, an increase of 5.75% compared to the previous year's 260.30 billion. Earnings were 4.55 billion, an increase of 20.82%.

Financial Statements

News

There is no news available yet.